Endo Pharmaceuticals, 7% 15jul2019, USD (FIGI BBG0027GGVD2)

Download

Copy issue information to clipboard

Copy to clipboard

Data copied to the clipboard

PDF download

Choose all Reset all

Download Cancel

International bonds

Status

Early redeemed

Amount

481,894,000 USD

Placement

***

Early redemption

*** (-)

ACI

Country of risk

USA

Current coupon

Price

Yield / Duration

Placement amount

481,894,000 USD
Minimum Settlement Amount

2,000 USD
CFI

DBFUGR
FIGI

BBG0027GGVD2
Ticker

ENDP 7 07/15/19

Try in 7-days Trial access

Free for company representative

Get full online access to the database
Use our powerful bond screener
Track bond prices from 400+ sources
Smart Portfolio Monitoring
Evaluate advanced analytical tools

Why Cbonds?

24 Years of Market Leadership
Trusted by clients across 90 countries for decades of reliable service
Used by Financial Professionals & Fintech central banks, asset managers, fintech innovators
Convenient platform for private investors for informed investment decisions

New to Cbonds? · Take a 90-second tour of the platform.

Discover what you can do with Cbonds

Everything you need for fixed income research and monitoring.

00:23 Coverage
00:40 Bond screener
00:54 Parameters
01:10 Watchlist, Mobile app
01:15 Excel Add-in

Get access Watch full tour

Trading chart

Stock exchange selection

More about Cbonds Estimation

No more than two exchanges can be selected for comparison at the same time

Bond is not traded; the issue is redeemed

Data display in a chart | table

Work with the chart: switching the price, period, issue comparison

Customize fields in the table

Found:

Show all fields

from

ADD-IN
Cbonds add-in API
bond data api

Authorization required

You need to request access

* Data is not available within the selected subscription

Explore the most comprehensive database

1 000 000

bonds

100 000

stocks

175 910

ETF & Funds

100 000

indices

Track your portfolio in the most efficient way

Bond Search
Watchlist
Excel ADD-IN

Get access

— Are you looking for the complete & verified bond data?

— We have everything you need:

full data on over 1 000 000 bonds, 100 000 stocks, 100 000 indices, 17 000 ETF and 150 000 Mutual Funds; powerful bond screener; over 350 pricing sources among stock exchanges & OTC market; ratings & financial reports; user-friendly interface; available anywhere via Website, Excel Add-in and Mobile app.

Why

You will have detailed descriptive & pricing data for 1M bonds, 100K stocks, 100K indices, 17K ETF and 150K Mutual Funds

Get full access to the platform from any device & via Cbonds app

Enhance your portfolio management with Cbonds Excel Add-in

Build yield maps, make chart comparison within a click

Don't wait any longer — start using Cbonds today! Register

Issue information

Profile

Endo Pharmaceuticals Solutions Inc. develops products to treat conditions in urology and endocrinology in the United States. The company was formerly known as Indevus Pharmaceuticals Inc. As a result of the acquisition of Indevus Pharmaceuticals Inc. by Endo Pharmaceuticals, Inc., Indevus Pharmaceuticals Inc.'s name was changed. The company was founded in 1988 and is based in Chadds Ford, Pennsylvania. As of March 18, 2009, Endo Pharmaceuticals Solutions Inc. operates as a subsidiary of Endo Pharmaceuticals Inc.

Show more Hide

Research report by Cbonds-PRAAMS

Save

Authorization required

Report download is available only paid Premium subscription access

Borrower

Go to the issuer page
Endo Pharmaceuticals
Full borrower / issuer name

Endo Pharmaceuticals
Sector

Corporate
Industry

Miscellaneous Healthcare: Products and Services

Volume

Placement amount

481,894,000 USD

Face value

Minimum Settlement Amount

2,000 USD
Outstanding face value

*** USD

Get access to the largest bond database

Try in 7-days Demo access

Free for company representative

Evaluate advanced analytical tools
Get full online access to the database
Try our powerful bond screener
Track bond prices from 400+ sources

Get access to the largest bond database

Representative of the company 7 days FREE trial

Professional access to the data

Private investor

Individual access

Cash flow parameters

Reference rate

***

Coupon Rate

***

Day count convention

***

Interest Accrual Date

***

Coupon frequency

*** time(s) per year
Payment currency

***
Maturity date

***
Early redemption date

***

Cash flow

Calculations for international bonds are made according to the minimum trading lot

Export to Excel

Early redemption terms

***

Explore the most comprehensive database

1 000 000

bonds

100 000

stocks

175 910

ETF & Funds

100 000

indices

Track your portfolio in the most efficient way

Bond Search
Watchlist
Excel ADD-IN

Get access

— Are you looking for the complete & verified bond data?

— We have everything you need:

Why

You will have detailed descriptive & pricing data for 1M bonds, 100K stocks, 100K indices, 17K ETF and 150K Mutual Funds

Get full access to the platform from any device & via Cbonds app

Enhance your portfolio management with Cbonds Excel Add-in

Build yield maps, make chart comparison within a click

Don't wait any longer — start using Cbonds today! Register

Placement

Placement method

Open subscription
Placement type

Public
Placement

***
Geographic breakdown

***
Investor breakdown

***

Conversion and exchange

Conversion terms

***

Latest issues

Show all

Similar issues

Identifiers

ISIN

***
Cbonds ID

104225
CUSIP

***
CUSIP 144A

***
CFI

DBFUGR
FIGI

BBG0027GGVD2
Ticker

ENDP 7 07/15/19
Type of security by CBR

***

Bond classification

Rank: Undefined
Registered
Coupon bonds
Amortization
Callable
CDO
Convertible
Dual currency bonds
Variable rate
For qualified investors (CIS region)
Foreign bonds
Green bonds
Guaranteed
Inflation-linked principal
Supranational bond issues
Inflation-linked coupon
Mortgage bonds
Non-complex financial instruments (MiFID)
Perpetual
Payment-in-kind
Non-Marketable Securities
Redemption Linked
Restructuring
Retail bonds
Covered
Securitization
Structured product
Commercial Bonds
Subordinated
Sukuk
Trace-eligible

Show more Hide

Restructuring

***